Susan Altschuller
Financieel Directeur/CFO bij CEREVEL THERAPEUTICS HOLDINGS, INC.
Vermogen: 711 530 $ op 30-04-2024
Actieve functies van Susan Altschuller
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CEREVEL THERAPEUTICS HOLDINGS, INC. | Financieel Directeur/CFO | 15-05-2023 | - |
Vestaron Corp.
Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC. | Directeur/Bestuurslid | - | - |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | Financieel Directeur/CFO | 01-05-2023 | - |
Loopbaan van Susan Altschuller
Eerdere bekende functies van Susan Altschuller
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
IMMUNOGEN, INC. | Financieel Directeur/CFO | 20-07-2020 | 23-12-2022 |
ALEXION PHARMACEUTICALS, INC. | Investor Relations Contact | 01-01-2018 | 01-04-2020 |
Corporate Officer/Principal | 01-04-2020 | 01-07-2020 | |
BIOVERATIV INC | Public Communications Contact | 01-08-2016 | 01-01-2018 |
BIOGEN INC. | Investor Relations Contact | - | - |
Opleiding van Susan Altschuller
Tulane University (Louisiana) | Undergraduate Degree |
Illinois Institute of Technology | Doctorate Degree |
MIT Sloan School of Management | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 11 |
Operationeel
Director of Finance/CFO | 3 |
Investor Relations Contact | 2 |
Corporate Officer/Principal | 2 |
Sectoraal
Health Technology | 7 |
Consumer Services | 4 |
Process Industries | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
BIOGEN INC. | Health Technology |
IMMUNOGEN, INC. | Health Technology |
CEREVEL THERAPEUTICS HOLDINGS, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Bioverativ, Inc.
Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
Vestaron Corp.
Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC. | Process Industries |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | Health Technology |
- Beurs
- Insiders
- Susan Altschuller
- Ervaring